You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
LIPID BLEND NANOCARRIER SCAFFOLD FOR ORAL BIOAVAILABILITY ENHANCEMENT OF EXEMESTANE
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-FDP-024
- By: SINGH, Archu (Jamia Hamdard, Jamia Hamdard, India)
- Co-author(s): Archu Singh: Pharmaceutics, Jamia Hamdard, New Delhi, India
Kanchan Kohli: Pharmaceutics, Jamia Hamdard, New Delhi, India - Abstract:
Background
Exemestane (EXE) is a novel oral steroidal aromatase inhibitor, approved for the treatment of breast cancer. However, its oral clinical application is limited because of low aqueous solubility and low oral bioavailability.
Methods
EXE loaded NLCs were using Precirol® ATO5 and Flaxseed as the solid lipid and liquid lipid respectively by
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026